Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial

BACKGROUND: Chronic hepatitis B (CHB) can progress to cirrhosis, hepatocellular carcinoma (HCC) and ultimately liver-related death. Although oral antiviral therapy for patients with CHB reduces the risk of such complications, once cirrhosis is established, the benefits of antiviral therapy are not r...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Jianhui, Yu, Zujiang, Li, Qin, Chen, Yongping, Xiang, Dedong, Tan, Lin, Lei, Chunliang, Bai, Wenlin, Li, Hongyan, Shang, Qinghua, Chen, Liang, Hu, Xiaoyu, Lu, Wei, Li, Zhiqin, Chen, Da, Wang, Xiaodong, Zhang, Changjiang, Xiao, Guangming, Qi, Xun, Chen, Jing, Zhou, Li, Chen, Guofeng, Li, Yonggang, Zeng, Zhen, Rong, Guanghua, Dong, Zheng, Chen, Yan, Lou, Min, Wang, Chunping, Lu, Yinying, Zhang, Cuihong, Yang, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234899/
https://www.ncbi.nlm.nih.gov/pubmed/25381721
http://dx.doi.org/10.1186/1745-6215-15-438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234899/
https://www.ncbi.nlm.nih.gov/pubmed/25381721
http://dx.doi.org/10.1186/1745-6215-15-438

Ejemplares similares